Teen cannabis users 60% less likely to complete school or get a degree

Individuals who are daily users of cannabis before age 17 are over 60% less likely to complete high school or obtain a degree compared to those who have never used the drug, new research published in The Lancet Psychiatry journal shows. The large meta-analysis also indicates that daily users of cannabis during adolescence are seven times more likely to attempt suicide, have an 18 times greater chance of cannabis dependence, and are eight times as likely to use other illicit drugs in later life.

“Our findings are particularly timely given that several US states and countries in Latin America have made moves to decriminalise or legalise cannabis, raising the possibility that the drug might become more accessible to young people”, says Richard Mattick, study author and Professor of Drug and Alcohol Studies at the National Drug and Alcohol Research Centre, University of New South Wales, in Australia.

Cannabis is the most widely used illicit drug globally and recent statistics have shown that in some countries adolescents are starting cannabis use at a younger age and more adolescents are using cannabis heavily. In England, 4% of 11–15 year olds report cannabis use in the past month, roughly 7% of US high-school seniors are daily or near-daily cannabis users, and in Australia, around 1% of 14–19 year olds are daily users of the drug, whilst 4% use weekly.

In this study, a team of Australian and New Zealand researchers combined individual-level data on up to 3765 participants who used cannabis from three large, long-running longitudinal studies to find out more about the link between the frequency of cannabis use before the age of 17 years (never, less than monthly, monthly or more, weekly or more, or daily) and seven developmental outcomes up to the age of 30 years (completing high school, obtaining a university degree, cannabis dependence, use of other illicit drugs, suicide attempt, depression, and welfare dependence).

The researchers recorded clear and consistent associations between frequency of cannabis use during adolescence and most young adult outcomes investigated, even after controlling for 53 potential confounding factors including age, sex, ethnicity, socioeconomic status, use of other drugs, and mental illness. Importantly, they also noted that the risks increased relative to dose, with daily cannabis users showing the strongest effects.

According to the study’s lead author, Dr Edmund Silins:

Our results provide strong evidence that the prevention or delay of cannabis use is likely to have broad health and social benefits. Efforts to reform cannabis legislation should be carefully assessed to ensure they reduce adolescent cannabis use and prevent potentially adverse effects on adolescent development.

Writing in a linked Comment, Merete Nordentoft, Professor of Psychiatry at the University of Copenhagen in Denmark says:

The convincing results presented by Silins and colleagues are very valuable and highly appropriate at a time when several American states and countries in Latin America and Europe have decriminalised or legalised cannabis and allow unrestricted marketing of various formulations of the drug. Such changes in legislation will probably be followed by decreased prices and increased use, which will lead to more young people having difficulties with school completion and social and personal maturation, and will increase the risk of psychosis.

Source: http://www.thelancet.com/

Comments

  1. Herb Reason Herb Reason United States says:

    Teen alcohol use is associated with these things plus much worse.

    We are not legalizing for kids. Currently it is so available to kids that studies don't just ask if they can get cannabis, they ask how many hours it would take them to get it. A third of teens say it would take less than a few hours. Most have more than a couple of friends, so basically any teen can already get cannabis anytime they wanted. The federally funded Monitoring the Future Survey reports about 85% of high school seniors find marijuana "fairly easy to obtain". Their figure has changed little since 1975, never dropping below 81% in three decades of national surveys.

    Regular teen access will not increase with legalization, and will likely decrease as the main supply channels are moved above ground where they can be easily monitored. At the very least we would take the cannabis they are getting from the criminal drug dealer of unknown character, with unknown potency, unknown purity (it could be laced, contaminated, etc), who never ID's, and put the supply in the hands of licensed, regulated, retailers who are not going to try and also sell hard drugs, or even have access to hard drugs.

    The federal organization SAMHSA has shown that, despite greater acceptance and more lenient laws, the perceived availability of cannabis to youths aged 12 to 17 has dropped from 55% in 2002 to 48.6% in 2010. Multiple peer-reviewed studies have shown that medical marijuana laws have not led to increased teen usage [Choo et al. 2014; Lynne-Landsman et al. 2013; Harper et al. 2012; Anderson et al. 2012].

    Teen usage dropped in Portugal since they decriminalized in 2001. The Netherlands have tolerated sales for years in 'coffee shops'. Both countries have lower usage rates, 3.3% and 5.4% respectively, than the U.S. which is 13.7%. Note that in the same time frame in which the war on drugs has been waging, tobacco use has dropped from about 45% to 18%, without criminalizing millions of tobacco users, whereas cannabis use went up.


    Lenient cannabis policies are not associated with elevated adolescent use:

    "the data provide no evidence that strict marijuana laws in the United States provide protective effects compared to the similarly restrictive but less vigorously enforced laws in place in Canada, and the regulated access approach in the Netherlands. " Simons-Morton et al. Cross-national comparison of adolescent drinking and cannabis use in the United States, Canada, and the Netherlands. Int J Drug Policy. 2010.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study links cannabis use to genotoxicity and transgenerational health impacts